Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

2B or not 2B: a tail of two NMDA receptor subunits.

Cepeda C, Levine MS.

Neuron. 2012 May 10;74(3):426-8. doi: 10.1016/j.neuron.2012.04.011.

2.

Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.

Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC.

Cell Calcium. 2012 Feb;51(2):95-106. doi: 10.1016/j.ceca.2011.11.008. Epub 2011 Dec 15.

PMID:
22177709
3.

Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit.

Otton HJ, Janssen A, O'Leary T, Chen PE, Wyllie DJ.

Eur J Pharmacol. 2009 Jul 1;614(1-3):14-21. doi: 10.1016/j.ejphar.2009.04.034. Epub 2009 Apr 24.

PMID:
19394328
4.

NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear.

Dalton GL, Wu DC, Wang YT, Floresco SB, Phillips AG.

Neuropharmacology. 2012 Feb;62(2):797-806. doi: 10.1016/j.neuropharm.2011.09.001. Epub 2011 Sep 10.

PMID:
21925518
5.

Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain.

Stroebel D, Carvalho S, Paoletti P.

Neuropharmacology. 2011 Jan;60(1):151-8. doi: 10.1016/j.neuropharm.2010.07.003. Epub 2010 Jul 16.

PMID:
20621105
6.
7.

GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.

Kiss JP, Szasz BK, Fodor L, Mike A, Lenkey N, Kurkó D, Nagy J, Vizi ES.

Neurochem Int. 2012 Jan;60(2):170-6. doi: 10.1016/j.neuint.2011.12.005. Epub 2011 Dec 17.

PMID:
22197911
8.

Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function.

Punnakkal P, Jendritza P, Köhr G.

Neuropharmacology. 2012 Apr;62(5-6):1985-92. doi: 10.1016/j.neuropharm.2011.12.018. Epub 2012 Jan 8.

PMID:
22245680
9.

Role of GluN2A and GluN2B subunits in the formation of filopodia and secondary dendrites in cultured hippocampal neurons.

Henle F, Dehmel M, Leemhuis J, Fischer C, Meyer DK.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb;385(2):171-80. doi: 10.1007/s00210-011-0701-3. Epub 2011 Oct 28.

PMID:
22033802
10.

Specific involvement of postsynaptic GluN2B-containing NMDA receptors in the developmental elimination of corticospinal synapses.

Ohno T, Maeda H, Murabe N, Kamiyama T, Yoshioka N, Mishina M, Sakurai M.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15252-7. doi: 10.1073/pnas.0906551107. Epub 2010 Aug 9.

11.

[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].

Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.

Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2479-84. Chinese.

PMID:
17156678
12.

A three amino acid tail following the TM4 region of the N-methyl-D-aspartate receptor (NR) 2 subunits is sufficient to overcome endoplasmic reticulum retention of NR1-1a subunit.

Yang W, Zheng C, Song Q, Yang X, Qiu S, Liu C, Chen Z, Duan S, Luo J.

J Biol Chem. 2007 Mar 23;282(12):9269-78. Epub 2007 Jan 25.

13.

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.

Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, Meissirel C, Honnorat J, Groc L.

Brain. 2012 May;135(Pt 5):1606-21. doi: 10.1093/brain/aws092.

14.

Regulation of NMDA receptors by the tyrosine kinase Fyn.

Trepanier CH, Jackson MF, MacDonald JF.

FEBS J. 2012 Jan;279(1):12-9. doi: 10.1111/j.1742-4658.2011.08391.x. Epub 2011 Dec 5. Review.

15.

N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1.

Waxman EA, Baconguis I, Lynch DR, Robinson MB.

J Biol Chem. 2007 Jun 15;282(24):17594-607. Epub 2007 Apr 25.

17.
18.

Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.

Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.

Mol Pharmacol. 1996 Dec;50(6):1541-50.

PMID:
8967976
19.

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019. Epub 2011 Dec 14.

PMID:
22198502
20.

Diminished prevalence but preserved synaptic distribution of N-methyl-D-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain.

Maliszewska-Cyna E, Bawa D, Eubanks JH.

Neuroscience. 2010 Jul 14;168(3):624-32. doi: 10.1016/j.neuroscience.2010.03.065. Epub 2010 Apr 7.

PMID:
20381590
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk